Vanishing Pancreatic Cysts during Follow-Up: Another Step Towards De-Emphasizing Cyst Size as a Major Clinical Predictor of Malignancy

Abstract

Introduction: In the management of pancreatic cystic neoplasms (PCN), size plays a crucial role as the expression of disease progression. While many evidences regarding the natural history of growing pancreatic cysts exist, almost no data are available regarding cysts with a reduction in size. Methods: Radiological and clinical data from patients of the dedicated pancreatic cysts outpatient clinic of the Department of General and Pancreatic Surgery, University of Verona Hospital were retrospectively reviewed. Patients diagnosed with PCNs reducing in size during follow-up were reviewed. Results: From a total of 3,146 patients, we identified 12 (0.38%) vanishing/reducing cysts without a history of pancreatitis. Most of them were presumed IPMN (66.6%). The median follow-up was 69 months and the median cyst’s size 30 mm (range 10–49). Most of the patients (75%) experienced a reduction in cyst size (median reduction of 8 mm, range 6–22) after a median time of 12 months (range 6–63), 3 patients experienced a complete disappearance of the cyst. Conclusion: Cyst size reduction during follow-up is a rare phenomenon of unknown explanation. It adds to the debate regarding the role of size as a clinical predictor whenever a definite diagnosis of a PCN cannot be reached.

Progression vs Cyst Stability of Branch-Duct Intraductal Papillary Mucinous Neoplasms After Observation and Surgery

“…The point of view changed dramatically by considering patients from their initial evaluation and regardless of results of final pathological evaluation. This allowed us to present a more accurate picture of presumed BD IPMNs, recalibrating the rates of malignant disease to lower values and resizing the role of several factors known to be associated with development of malignant disease, such as cyst size, cyst growth rate, and main pancreatic duct dilatation . This new approach, however, raised several new concerns, such as the possibility of underestimating the risk of malignant progression, considering the substantial rate of misdiagnosis, and the absence of pathological confirmation for patients under surveillance.…”

Serous Cystic Neoplasms of the Pancreas Management in the Real-world

“…The remaining 4 patients were diagnosed as follows: 1 patient was diagnosed with lymphocele, 1 was diagnosed with pancreatic pseudocyst, and 2 were diagnosed with a vanishing pancreatic cyst. 34 None of these latter 4 patients required surgery.…”